Liangxue-Qushi-Zhiyang Decoction Ameliorates DNCB-Induced Atopic Dermatitis in Mice Through the MAPK Signaling Pathway Based on Network Pharmacology

Overview

Journal ACS Omega

Publisher American Chemical Society

Specialty Chemistry

Date 2024 Apr 29

PMID 38680355

Authors

Lili Zhang

Huili Zhang

Xiaoyu Niu

Xuan Zhang

Xingtong Chen

Shengyi Lei

Shengnan Ma

Zhanxue Sun

Affiliations

Soon will be listed here.

Abstract

The traditional prescription of Liangxue-Qushi-Zhiyang decoction (LQZ) has been demonstrated to be efficacious in treating atopic dermatitis (AD), a chronic inflammatory skin disorder marked by intense itching, redness, rashes, and skin thickening. Nevertheless, there has been an inadequate systematic exploration of the potential targets, biological processes, and pathways for AD treatment through LQZ. The study objective was to evaluate the efficacy and possible mechanism of LQZ in AD mice. In our study, we identified the primary compounds of LQZ, analyzed hub targets, and constructed a network. Subsequently, the predicted mechanisms of LQZ in AD were experimentally studied and validated in vivo, as determined by network pharmacological analysis. A total of 80 serum components of LQZ were identified through ultra-performance liquid chromatography-electrospray ionization-tandem mass spectrometry (UPLC-ESI-MS/MS), among which 49 compounds were absorbed into the bloodstream. Our results indicated that LQZ targets six putative key factors in the MAPK signaling pathway, which play essential roles in AD, namely, EGFR, p-MAPK1/3, p-MAPK14, IL-1β, IL-6, and TNF-α. We observed spleen coefficient, dermatitis scores, and ear thickness were all downregulated in 2,4-dinitrochlorobenzene (DNCB)-induced mice after LQZ treatment. Histological analysis of the dorsal and ear skin further revealed that LQZ significantly decreased skin inflammation, epidermal thickness, and mast cell numbers compared to the DNCB group. Our study demonstrated the effectiveness of LQZ in reducing epidermal and dermal damage in a mouse model of AD. Furthermore, our findings suggest that downregulating the MAPK signaling pathway could be a potential therapeutic strategy for the treatment of AD.

References

Liu J, Tao Y, Zou X, Liu Q, Meng X, Zhang Y . In vitro and in vivo exploration of the anti-atopic dermatitis mechanism of action of Tibetan medicine Qi-Sai-Er-Sang-Dang-Song decoction. J Ethnopharmacol. 2023; 306:116155. DOI: 10.1016/j.jep.2023.116155. View

Liang X, Huang Y, Pan X, Hao Y, Chen X, Jiang H . Erucic acid from suppresses influenza A virus replication and inflammation and through modulation of NF-κB and p38 MAPK pathway. J Pharm Anal. 2020; 10(2):130-146. PMC: 7192973. DOI: 10.1016/j.jpha.2019.09.005. View

Huang D, Sherman B, Lempicki R . Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009; 4(1):44-57. DOI: 10.1038/nprot.2008.211. View

Tan Y, Huang Z, Liu Y, Li X, Stalin A, Fan X . Integrated serum pharmacochemistry, 16S rRNA sequencing and metabolomics to reveal the material basis and mechanism of Yinzhihuang granule against non-alcoholic fatty liver disease. J Ethnopharmacol. 2023; 310:116418. DOI: 10.1016/j.jep.2023.116418. View

Traidl S, Roesner L, Zeitvogel J, Werfel T . Eczema herpeticum in atopic dermatitis. Allergy. 2021; 76(10):3017-3027. DOI: 10.1111/all.14853. View

Huang M, Hua N, Zhuang S, Fang Q, Shang J, Wang Z . proliferative basal cells promote epidermal hyperplasia in chronic dry skin disease identified by single-cell RNA transcriptomics. J Pharm Anal. 2023; 13(7):745-759. PMC: 10422139. DOI: 10.1016/j.jpha.2023.04.004. View

Weidinger S, Beck L, Bieber T, Kabashima K, Irvine A . Atopic dermatitis. Nat Rev Dis Primers. 2018; 4(1):1. DOI: 10.1038/s41572-018-0001-z. View

Fraga C, Clowers B, Moore R, Zink E . Signature-discovery approach for sample matching of a nerve-agent precursor using liquid chromatography-mass spectrometry, XCMS, and chemometrics. Anal Chem. 2010; 82(10):4165-73. DOI: 10.1021/ac1003568. View

Stelzer G, Rosen N, Plaschkes I, Zimmerman S, Twik M, Fishilevich S . The GeneCards Suite: From Gene Data Mining to Disease Genome Sequence Analyses. Curr Protoc Bioinformatics. 2016; 54:1.30.1-1.30.33. DOI: 10.1002/cpbi.5. View

10.

Wang H, Wu R, Xie D, Ding L, Lv X, Bian Y . A Combined Phytochemistry and Network Pharmacology Approach to Reveal the Effective Substances and Mechanisms of Wei-Fu-Chun Tablet in the Treatment of Precancerous Lesions of Gastric Cancer. Front Pharmacol. 2020; 11:558471. PMC: 7768900. DOI: 10.3389/fphar.2020.558471. View

11.

Li Q, Jia C, Wu H, Liao Y, Yang K, Li S . Nao Tan Qing ameliorates Alzheimer's disease-like pathology by regulating glycolipid metabolism and neuroinflammation: A network pharmacology analysis and biological validation. Pharmacol Res. 2022; 185:106489. DOI: 10.1016/j.phrs.2022.106489. View

12.

Tsai Y, Chang H, Chou S, Chu T, Hsu Y, Hsiao C . Evaluation of the Anti-Atopic Dermatitis Effects of α-Boswellic Acid on Tnf-α/Ifn-γ-Stimulated HaCat Cells and DNCB-Induced BALB/c Mice. Int J Mol Sci. 2022; 23(17). PMC: 9456567. DOI: 10.3390/ijms23179863. View

13.

Guttman-Yassky E, Waldman A, Ahluwalia J, Ong P, Eichenfield L . Atopic dermatitis: pathogenesis. Semin Cutan Med Surg. 2017; 36(3):100-103. DOI: 10.12788/j.sder.2017.036. View

14.

Newsom M, Bashyam A, Balogh E, Feldman S, Strowd L . New and Emerging Systemic Treatments for Atopic Dermatitis. Drugs. 2020; 80(11):1041-1052. PMC: 7281689. DOI: 10.1007/s40265-020-01335-7. View

15.

Demchenko Y, Glebov O, Zingone A, Keats J, Bergsagel P, Kuehl W . Classical and/or alternative NF-kappaB pathway activation in multiple myeloma. Blood. 2010; 115(17):3541-52. PMC: 2867265. DOI: 10.1182/blood-2009-09-243535. View

16.

Barbarot S, Auziere S, Gadkari A, Girolomoni G, Puig L, Simpson E . Epidemiology of atopic dermatitis in adults: Results from an international survey. Allergy. 2018; 73(6):1284-1293. DOI: 10.1111/all.13401. View

17.

Hopkins A . Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol. 2008; 4(11):682-90. DOI: 10.1038/nchembio.118. View

18.

Barnes L, Kaya G, Rollason V . Topical corticosteroid-induced skin atrophy: a comprehensive review. Drug Saf. 2015; 38(5):493-509. DOI: 10.1007/s40264-015-0287-7. View

19.

Wollenberg A, Oranje A, Deleuran M, Simon D, Szalai Z, Kunz B . ETFAD/EADV Eczema task force 2015 position paper on diagnosis and treatment of atopic dermatitis in adult and paediatric patients. J Eur Acad Dermatol Venereol. 2016; 30(5):729-47. DOI: 10.1111/jdv.13599. View

20.

Williams H, Chalmers J . Prevention of Atopic Dermatitis. Acta Derm Venereol. 2020; 100(12):adv00166. PMC: 9189742. DOI: 10.2340/00015555-3516. View